Spyglass Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-652,841
| Closed | -$97.5M | – | 26 |
|
|
2024
Q3 | $97.5M | Sell |
652,841
-10,047
| -2% | -$1.5M | 6.4% | 2 |
|
|
2024
Q2 | $90.4M | Buy |
662,888
+48,781
| +8% | +$6.65M | 6.62% | 1 |
|
|
2024
Q1 | $92.8M | Buy |
614,107
+74,159
| +14% | +$11.2M | 6.18% | 2 |
|
|
2023
Q4 | $68M | Sell |
539,948
-74,670
| -12% | -$9.4M | 4.89% | 2 |
|
|
2023
Q3 | $57.6M | Sell |
614,618
-43,235
| -7% | -$4.05M | 4.51% | 9 |
|
|
2023
Q2 | $58.7M | Sell |
657,853
-56,113
| -8% | -$5.01M | 4.24% | 11 |
|
|
2023
Q1 | $76.6M | Sell |
713,966
-495
| -0.1% | -$53.1K | 5.77% | 2 |
|
|
2022
Q4 | $87.3M | Sell |
714,461
-235,454
| -25% | -$28.8M | 7.01% | 1 |
|
|
2022
Q3 | $98.1M | Sell |
949,915
-159,755
| -14% | -$16.5M | 6.94% | 1 |
|
|
2022
Q2 | $103M | Sell |
1,109,670
-94,320
| -8% | -$8.77M | 5.73% | 3 |
|
|
2022
Q1 | $141M | Sell |
1,203,990
-107,925
| -8% | -$12.7M | 4.83% | 8 |
|
|
2021
Q4 | $176M | Sell |
1,311,915
-66,972
| -5% | -$9.01M | 4.68% | 8 |
|
|
2021
Q3 | $220M | Buy |
1,378,887
+256,216
| +23% | +$40.8M | 5.04% | 6 |
|
|
2021
Q2 | $148M | Buy |
1,122,671
+151,566
| +16% | +$19.9M | 3.29% | 16 |
|
|
2021
Q1 | $125M | Buy |
971,105
+269,511
| +38% | +$34.7M | 3.3% | 18 |
|
|
2020
Q4 | $117M | Buy |
701,594
+154,572
| +28% | +$25.8M | 3.59% | 17 |
|
|
2020
Q3 | $84.4M | Buy |
547,022
+94,918
| +21% | +$14.6M | 3.9% | 14 |
|
|
2020
Q2 | $66.9M | Buy |
452,104
+100,716
| +29% | +$14.9M | 4.14% | 12 |
|
|
2020
Q1 | $39.6M | Buy |
351,388
+100,416
| +40% | +$11.3M | 4.47% | 11 |
|
|
2019
Q4 | $34.9M | Buy |
250,972
+117,283
| +88% | +$16.3M | 4.48% | 10 |
|
|
2019
Q3 | $12.9M | Buy |
133,689
+22,949
| +21% | +$2.21M | 3.42% | 17 |
|
|
2019
Q2 | $12.8M | Buy |
110,740
+20,675
| +23% | +$2.38M | 4.03% | 13 |
|
|
2019
Q1 | $10.6M | Buy |
90,065
+47,000
| +109% | +$5.53M | 4.1% | 14 |
|
|
2018
Q4 | $2.7M | Buy |
+43,065
| New | +$2.7M | 2.02% | 25 |
|